We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Stratasys
SSYS
$758M
| $13.2M | 0.1% |
635,390
+167,308
| +36% | +$2.69M |
|
202
RTX Corp
RTX
$299B
| $13.1M | 0.1% |
182,867
-91,911
| -33% | -$6.04M |
|
203
Zoetis
ZTS
$32.4B
| $13M | 0.1% |
78,709
+14,436
| +22% | +$2.35M |
|
204
Estee Lauder
EL
$30.8B
| $13M | 0.1% |
48,907
+663
| +1% | +$160K |
|
205
Veeva Systems
VEEV
$35B
| $12.9M | 0.1% |
47,338
+6,114
| +15% | +$1.71M |
|
206
State Street Communication Services Select Sector SPDR ETF
XLC
$22.3B
| $12.8M | 0.1% |
190,414
+17,687
| +10% | +$1.13M |
|
207
Varonis Systems
VRNS
$4.86B
| $12.7M | 0.1% |
+232,782
| New | +$10.1M |
|
208
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
| $12.6M | 0.1% |
104,664
+40,817
| +64% | +$4.91M |
|
209
BlackRock Municipal 2030 Target Term Trust
BTT
$1.43B
| $12.5M | 0.1% |
488,555
+5,595
| +1% | +$140K |
|
210
Standard Motor Products
SMP
$884M
| $12.3M | 0.09% |
302,942
+12,134
| +4% | +$570K |
|
211
Ares Capital
ARCC
$14.1B
| $12.2M | 0.09% |
722,649
+43,174
| +6% | +$669K |
|
212
Elevance Health
ELV
$84.4B
| $11.9M | 0.09% |
37,068
+7,827
| +27% | +$2.4M |
|
213
Enterprise Products Partners
EPD
$82.5B
| $11.8M | 0.09% |
602,182
+39,059
| +7% | +$727K |
|
214
Dover
DOV
$28.3B
| $11.7M | 0.09% |
92,725
+11,405
| +14% | +$1.35M |
|
215
iShares Biotechnology ETF
IBB
$9.5B
| $11.5M | 0.09% |
75,651
+23,888
| +46% | +$3.41M |
|
216
Illinois Tool Works
ITW
$84.6B
| $11.3M | 0.09% |
55,579
+5,179
| +10% | +$1.06M |
|
217
Energy Transfer Partners
ET
$71.4B
| $11.3M | 0.09% |
1,823,427
-137,130
| -7% | -$830K |
|
218
Analog Devices
ADI
$184B
| $11.2M | 0.08% |
75,748
+19,066
| +34% | +$2.53M |
|
219
Prudential Financial
PRU
$42.1B
| $11M | 0.08% |
141,423
+1,738
| +1% | +$126K |
|
220
iShares Morningstar Growth ETF
ILCG
$3.24B
| $10.9M | 0.08% |
188,060
+8,265
| +5% | +$459K |
|
221
Vanguard Health Care ETF
VHT
$18.3B
| $10.9M | 0.08% |
48,659
+484
| +1% | +$103K |
|
222
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $10.8M | 0.08% |
280,626
-9,573
| -3% | -$358K |
|
223
Lowe's Companies
LOW
$122B
| $10.8M | 0.08% |
67,190
+7,775
| +13% | +$1.26M |
|
224
Linde
LIN
$226B
| $10.8M | 0.08% |
40,873
+19,154
| +88% | +$4.7M |
|
225
iShares MSCI USA Quality Factor ETF
QUAL
$47.7B
| $10.7M | 0.08% |
91,764
+4,874
| +6% | +$537K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.